Correspondence 0001193125-24-138188 from Erasca, Inc. (ERAS)
Erasca, Inc.
Date: May 14, 2024 · CIK: 0001761918 · Accession: 0001193125-24-138188
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-279261
Letter
Erasca, Inc.
3115 Merryfield Row, Suite 300
San Diego, CA 92121
May 14, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Erasca, Inc.
Registration Statement on Form S-3
File No. 333-279261
To the addressees set forth above:
Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Erasca, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on May 16, 2024, or as soon as practicable thereafter.
If you have any questions or require additional information, please contact Matthew T. Bush, Esq. of Latham & Watkins LLP at (858) 523-3962. Thank you for your assistance and cooperation in this matter.
Very truly yours,
ERASCA, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Erasca, Inc. 3115 Merryfield Row, Suite 300 San Diego, CA 92121 May 14, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Erasca, Inc. Registration Statement on Form S-3 File No. 333-279261 To the addressees set forth above: Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Erasca, Inc., respectfully requests that the effective date of the Registration Statement on Form S-3 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on May 16, 2024, or as soon as practicable thereafter. If you have any questions or require additional information, please contact Matthew T. Bush, Esq. of Latham & Watkins LLP at (858) 523-3962. Thank you for your assistance and cooperation in this matter. Very truly yours, ERASCA, INC. By: /s/ Jonathan E. Lim Jonathan E. Lim, M.D. Chairman, Chief Executive Officer and Co-Founder cc: Ebun S. Garner, Erasca, Inc. Cheston J. Larson, Latham & Watkins LLP Matthew T. Bush, Latham & Watkins LLP